Relay Therapeutics, Inc.
RLAYBiotechnology
$18.35−5.75%As of Oct 30vs prior close
- Market cap
- $4B
- P/E (TTM)
- –
- From 52W high
- −11.57%
- EPS (LTM)
- -$1.56
- Revenue (LTM)
- $10.3M
- Net margin
- -2763.91%
- Dividend yield
- 0.00%
Nomior Score
58
Steady ProfileSpeculativeTop 31% of the scored universe
Growth58
Quality36
Value53
Momentum98
Resilience33
Growth
−28.58%revenue a year over 5 fiscal years
YE20 $82.7MLTM $10.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 25950% of revenue, wider by 14599 pts on a year.
Who owns it
2funds, 1 tracked portfolio